Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00045916 · ClinicalTrials.gov registry record · Phase 4

Optimizing Electroconvulsive Therapy for Depression

A Phase 4 study of Depression and Bipolar Disorder, sponsored by New York State Psychiatric Institute.

Completed
Registry status
Phase 4
Development phase
340
Enrollment target
4
Study locations

NCT00045916 is a Phase 4 study of Depression and Bipolar Disorder that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 340 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (57% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00045916, a Phase 4 study of Depression and Bipolar Disorder, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
Phase 4
Development phase
340 participants
Enrollment target
4
Study locations

Study Summary

This study will evaluate the effectiveness of electroconvulsive therapy (ECT) administered with medication for the treatment of a major depressive episode (unipolar or bipolar) and will compare two types of ECT.

Conditions Studied

Depression Bipolar Disorder Depressive Disorder

Interventions

  • DRUG Lithium
  • DRUG Nortriptyline
  • DRUG Venlafaxine
  • PROCEDURE High dosage electroconvulsive therapy
  • PROCEDURE Low dosage electroconvulsive therapy

Study Locations (4)

Missouri

  • Washington University - St Louis

New York

  • New York State Psychiatric Institute at Columbia University - New York

North Carolina

  • Wake Forest University - Winston-Salem

Pennsylvania

  • Western Psychiatric Institute and Clinic - Pittsburgh

Trial Details

FieldValue
Enrollment Target 340 participants
Start Date 2001-02
Est. Completion 2006-12
Phase Phase 4

Sponsor

New York State Psychiatric Institute

364 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00045916

The ClinicalTrials.gov registry entry for NCT00045916 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 340 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (57% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 5 interventions - of which Lithium is the first listed.

NCT00045916 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Missouri, New York, North Carolina.

Frequently Asked Questions

What is clinical trial NCT00045916 about?

NCT00045916 is a clinical study titled "Optimizing Electroconvulsive Therapy for Depression". This study will evaluate the effectiveness of electroconvulsive therapy (ECT) administered with medication for the treatment of a major depressive episode (unipolar or bipolar) and will compare two types of ECT.

What is the current status of trial NCT00045916?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 340 participants. The study started on 2001-02. Estimated completion is 2006-12.

What conditions does trial NCT00045916 study?

This clinical trial studies the following conditions: Depression, Bipolar Disorder, Depressive Disorder.

What interventions are being tested in trial NCT00045916?

The interventions under investigation include: Lithium (DRUG), Nortriptyline (DRUG), Venlafaxine (DRUG), High dosage electroconvulsive therapy (PROCEDURE), Low dosage electroconvulsive therapy (PROCEDURE).

Who is sponsoring clinical trial NCT00045916?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00045916 being conducted?

This trial has 4 study locations across Missouri, New York, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Depression

All registered trials for this condition

Bipolar Disorder

All registered trials for this condition

Missouri

All trials with a study site in Missouri

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.